Palisade Bio Inc expected to post a loss of 72 cents a share - Earnings Preview

Palisade Bio

09/05/2023 13:24

* Palisade Bio Inc  PALI.OQ   PALI.O  is expected to show no
change in quarterly revenue when it reports  results on May 11
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Palisade Bio Inc is
for a
loss of 72 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $15​, above​ its last closing price of $1.66. ​​​

This summary was machine generated May 9 at 12:24 GMT.  All
figures in US dollars  unless otherwise stated